Drug Detail

Information about Inlyta + Keytruda

Generic Name	Axitinib + Pembrolizumab
IND
Brand Name (US)	Inlyta + Keytruda
Manufacturer	Pfizer + Merck
Drug Type
Delivery	Oral
Approval Status	Approved for a non-GIST application
Indications	Kidney Cancer + Melanoma
Overall Strategy	KIT Protein and immune system
Strategy	Block KIT + Stimulate the immune system
Drug Category	KIT/PDGFRa inhibitor + PD-1 inhibitor

See individual separate records for these two drugs for additional links and information.